NAFDAC bans multi-dose malaria suspension over instability
NAFDAC has suspended all multi-dose Artemether/Lumefantrine dry powder for oral suspension due to instability when mixed with water, rendering it ineffective. The suspension affects all local and imported brands, with manufacturers now required to produce dispersible tablets or single-dose sachets instead. This decision follows studies showing reconstituted formulations lose efficacy, risking treatment failure and severe complications. Healthcare workers and the public are urged to report any sales of the discontinued products.